$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > IMpassion130

乳腺癌|乳腺癌特药

治疗局部晚期或转移性TNBC,atezolizumab+化疗降低死亡风险33%

阿替利珠单抗|上市信息

罗氏与FDA谈判后主动撤回阿替利珠单抗(T药)三阴性乳腺癌适应症

阿替利珠单抗|最新研究

新疗法!化免联合首次写入CSCO乳腺癌指南!化疗耐药以及术前新辅助治